Sums paid to Irish doctors and health institutions by pharma uncovered

8 November 2016

Payments which the pharmaceutical industry made to doctors, hospitals and other aspects of Ireland’s healthcare framework have been laid bare by a new investigation.

Irish newspaper The Sunday Business Post revealed that pharma payments to the country’s doctors totalled 6.8 million euros ($7.5 million) in 2015, while healthcare institutions received 10.7 euros from the industry.

The report also stated that dozens of medical and nursing posts in Irish hospitals are being funded by the sector, which is paying almost one-third of the country’s most senior public sector doctors.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK